Sodium hydride → 4-[(2,4-dichlorophenyl)amino]-3-{2-[4-(1-ethoxyethoxy)phenyl]-1-methyl-2-oxoethyl}-1-piperidin-1-yl-5,6-dihydropyridin-2(1H)-one
反応式
[Cl:1][C:2]1[CH:7]=[C:6]([Cl:8])[CH:5]=[CH:4][C:3]=1[NH:9][C:10]1[CH2:15][CH2:14][N:13]([N:16]2[CH2:21][CH2:20][CH2:19][CH2:18][CH2:17]2)[C:12](=[O:22])[CH:11]=1.[H-].[Na+].Br[CH:26]([CH3:41])[C:27]([C:29]1[CH:34]=[CH:33][C:32]([O:35][CH:36]([O:38][CH2:39][CH3:40])[CH3:37])=[CH:31][CH:30]=1)=[O:28]>C1COCC1.[I-].C([N+](CCCC)(CCCC)CCCC)CCC>[Cl:1][C:2]1[CH:7]=[C:6]([Cl:8])[CH:5]=[CH:4][C:3]=1[NH:9][C:10]1[CH2:15][CH2:14][N:13]([N:16]2[CH2:21][CH2:20][CH2:19][CH2:18][CH2:17]2)[C:12](=[O:22])[C:11]=1[CH:26]([CH3:41])[C:27]([C:29]1[CH:34]=[CH:33][C:32]([O:35][CH:36]([O:38][CH2:39][CH3:40])[CH3:37])=[CH:31][CH:30]=1)=[O:28]参加物
反応物 3
生成物 1
試薬・触媒・溶媒 2
実験手順
4-[(2,4-dichlorophenyl)amino]-1-piperidin-1-yl-5,6-dihydropyridin-2(1H)-one (450 mg, 1.323 mmol) suspended in THF (7 ml) was added during 15 min to NaH (67 mg, 2.645 mmol) suspended in THF (5 ml) at 5° C. under nitrogen. After the resulting mixture had been stirred at 0° C. for 1 h tetrabutylammonium iodide (49 mg, 0.132 mmol) was added followed by dropwise addition of 2-bromo-1-[4-(1-ethoxyethoxy)phenyl]propan-1-one (597 mg, 1.984 mmol) dissolved in THF (5 ml) during 15 min. After the addition the cooling bath was removed and the reaction was continued at rt overnight. Water was added and the solvent was removed by evaporation. The residue was partitioned between DCM and water. The organic phase was dried (MgSO4), filtered and evaporated to yield an orange oil (1.030 g, 90%).
後処理
- additionwas added
- additionAfter the addition the cooling bath
- customwas removed
- additionWater was added
- customthe solvent was removed by evaporation
- customThe residue was partitioned between DCM and water
- dry with materialThe organic phase was dried (MgSO4)
- filtrationfiltered
- customevaporated
出典と根拠
- ORDレコード
- ord-f19bad9e5e5e414f8ac117ac4af3749f
- 出典データセット
- uspto-grants-2009_08
- 特許番号
- US07576095B2
反応ノート
読み込み中…